HealthEquity Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for HealthEquity stock have an average target of 112.58, with a low estimate of 94 and a high estimate of 130. The average target predicts an increase of 35.59% from the current stock price of 83.03.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$94	$112.58	$112	$130
Change	+13.21%	+35.59%	+34.89%	+56.57%

Analyst Ratings

The average analyst rating for HealthEquity stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	3	3	3	3	4	4
Buy	8	9	9	9	8	7
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	13	13	13	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alexander Paris Barrington Research	Barrington Research	Buy Maintains $112	Buy	Maintains	$112	+34.89%	Apr 11, 2025
David Roman Goldman Sachs	Goldman Sachs	Hold Maintains $107 → $94	Hold	Maintains	$107 → $94	+13.21%	Mar 27, 2025
C. Gregory Peters Raymond James	Raymond James	Buy → Strong Buy Upgrades $120 → $115	Buy → Strong Buy	Upgrades	$120 → $115	+38.50%	Mar 25, 2025
Scott Schoenhaus Keybanc	Keybanc	Buy Maintains $120 → $110	Buy	Maintains	$120 → $110	+32.48%	Mar 24, 2025
Alexander Paris Barrington Research	Barrington Research	Buy Maintains $112	Buy	Maintains	$112	+34.89%	Mar 19, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.32B

from 1.20B

9.60%

from 1.20B

Revenue Next Year

1.45B

from 1.32B

10.19%

from 1.32B

EPS This Year

3.69

from 1.09

238.75%

from 1.09

EPS Next Year

4.54

from 3.69

22.84%

from 3.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jan 31, 2021	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027	Jan 31, 2028
Revenue	733.57M	756.56M	861.75M	999.59M	1.20B	1.32B	1.45B	1.61B
Revenue Growth	37.89%	3.13%	13.90%	16.00%	20.03%	9.60%	10.19%	11.04%
EPS	0.12	-0.53	-0.31	0.64	1.09	3.69	4.54	5.40
EPS Growth	-79.48%	-	-	-	70.31%	238.75%	22.84%	19.02%
Forward PE	-	-	-	-	-	22.49	18.31	15.38
No. Analysts	-	-	-	-	-	15	13	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	1.4B	1.6B	1.8B
Avg	1.3B	1.4B	1.6B
Low	1.3B	1.4B	1.5B

Revenue Growth

Revenue Growth	2026	2027	2028
High	14.9%	20.9%	21.0%
Avg	9.6%	10.2%	11.0%
Low	5.8%	3.3%	0.8%

EPS Forecast

EPS	2026	2027	2028
High	3.98	5.03	5.67
Avg	3.69	4.54	5.40
Low	3.48	4.17	5.18

EPS Growth

EPS Growth	2026	2027	2028
High	265.1%	36.2%	25.0%
Avg	238.8%	22.8%	19.0%
Low	219.2%	13.1%	14.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.